Michael G. Kauffman

2018

In 2018, Michael G. Kauffman earned a total compensation of $2.3M as Chief Executive Officer at Karyopharm Therapeutics, a 14% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$268,625
Option Awards$1,444,660
Salary$550,000
Other$11,660
Total$2,274,945

Kauffman received $1.4M in option awards, accounting for 64% of the total pay in 2018.

Kauffman also received $268.6K in non-equity incentive plan, $550K in salary and $11.7K in other compensation.

Rankings

In 2018, Michael G. Kauffman's compensation ranked 5,071st out of 14,244 executives tracked by ExecPay. In other words, Kauffman earned more than 64.4% of executives.

ClassificationRankingPercentile
All
5,071
out of 14,244
64th
Division
Manufacturing
1,908
out of 5,762
67th
Major group
Chemicals And Allied Products
700
out of 2,125
67th
Industry group
Drugs
586
out of 1,814
68th
Industry
Pharmaceutical Preparations
451
out of 1,388
68th
Source: SEC filing on April 19, 2019.

Kauffman's colleagues

We found four more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2018.

2018

Anand Varadan

Karyopharm Therapeutics

Executive Vice President, Chief Commercial Officer

2018

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2018

Christopher Primiano

Karyopharm Therapeutics

General Counsel

2018

Michael MSM

Karyopharm Therapeutics

Chief Financial Officer

News

In-depth

You may also like